Companies in Massachusetts

Page: 1 of 7
Region:   North America
Displaying 1-50 of 306 results Download this list
Name Symbol Market Cap ADR TSO Country IPO Year Subsector
THL Credit, Inc. n/a United States 2014 n/a
Tecogen Inc. $79.2M United States 2014 Industrial Machinery/Components
Flexion Therapeutics, Inc. $327.24M United States 2014 Major Pharmaceuticals
Genocea Biosciences, Inc. $129.08M United States 2014 Biotechnology: Biological Products (No Diagnostic Substances)
Concert Pharmaceuticals, Inc. $222.78M United States 2014 Major Pharmaceuticals
Eleven Biotherapeutics, Inc. $194.01M United States 2014 Major Pharmaceuticals
Aldeyra Therapeutics, Inc. $37.51M United States 2014 Major Pharmaceuticals
Dicerna Pharmaceuticals, Inc. $249.54M United States 2014 Major Pharmaceuticals
Cerulean Pharma Inc. $124.98M United States 2014 Major Pharmaceuticals
Akebia Therapeutics, Inc. $241.45M United States 2014 Major Pharmaceuticals
Melrose Bancorp, Inc. $37.27M United States 2014 Major Banks
Minerva Neurosciences, Inc $87.96M United States 2014 Major Pharmaceuticals
Histogenics Corporation $140.32M United States 2014 n/a
Tokai Pharmaceuticals, Inc. $321.18M United States 2014 Major Pharmaceuticals
T2 Biosystems, Inc. $360.95M United States 2014 Medical/Dental Instruments
Zafgen, Inc. $537.26M United States 2014 Major Pharmaceuticals
Sage Therapeutics, Inc. $1.02B United States 2014 Major Pharmaceuticals
Proteon Therapeutics, Inc. $165.64M United States 2014 Biotechnology: Biological Products (No Diagnostic Substances)
CB Pharma Acquisition Corp. n/a United States 2014 n/a
Bright Horizons Family Solutions Inc. $3.01B United States 2013 Other Consumer Services
Enanta Pharmaceuticals, Inc. $788.63M United States 2013 Major Pharmaceuticals
Epizyme, Inc. $615.28M United States 2013 Major Pharmaceuticals
bluebird bio, Inc. $2.53B United States 2013 Biotechnology: Biological Products (No Diagnostic Substances)
Agios Pharmaceuticals, Inc. $4.03B United States 2013 Major Pharmaceuticals
Foundation Medicine, Inc. $619.94M United States 2013 Medical Specialities
BIND Therapeutics, Inc. $94.98M United States 2013 Major Pharmaceuticals
Endurance International Group Holdings, Inc. $2.22B United States 2013 Computer Software: Prepackaged Software
Acceleron Pharma Inc. $1.28B United States 2013 Biotechnology: Biological Products (No Diagnostic Substances)
Karyopharm Therapeutics Inc. $1.07B United States 2013 Major Pharmaceuticals
Houghton Mifflin Harcourt Company $2.84B United States 2013 Books
Affiliated Managers Group, Inc. n/a United States 2012 Investment Managers
Equity Commonwealth n/a United States 2012 Real Estate Investment Trusts
M/A-COM Technology Solutions Holdings, Inc. $1.47B United States 2012 Semiconductors
Brightcove Inc. $230.1M United States 2012 EDP Services
Wellesley Bancorp, Inc. $46.24M United States 2012 Banks
Exa Corporation $152.21M United States 2012 Computer Software: Prepackaged Software
Verastem, Inc. $215.96M United States 2012 Major Pharmaceuticals
TESARO, Inc. $1.33B United States 2012 Major Pharmaceuticals
Stag Industrial, Inc. $1.61B United States 2011 Real Estate Investment Trusts
Dunkin' Brands Group, Inc. $4.83B United States 2011 Restaurants
BSB Bancorp, Inc. $170.48M United States 2011 Major Banks
THL Credit, Inc. $397.71M United States 2010 n/a
AVEO Pharmaceuticals, Inc. $37.08M United States 2010 Major Pharmaceuticals
Ironwood Pharmaceuticals, Inc. $2.05B United States 2010 Major Pharmaceuticals
Peoples Federal Bancshares, Inc. $137.21M United States 2010 Banks
LPL Financial Holdings Inc. $4.32B United States 2010 Investment Bankers/Brokers/Service
Ameresco, Inc. $350.87M United States 2010 Engineering & Construction
Eaton Vance Municipal Income Trust $322.35M United States 2009 n/a
LogMein, Inc. $1.15B United States 2009 Computer Software: Prepackaged Software
Synta Pharmaceuticals Corp. $296.2M United States 2007 Major Pharmaceuticals
*IPO year information is not available for stocks prior to 1970.